Stay updated on Navarixin and Pembrolizumab Combination Clinical Trial
Sign up to get notified when there's something new on the Navarixin and Pembrolizumab Combination Clinical Trial page.

Latest updates to the Navarixin and Pembrolizumab Combination Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedAdds a recruitment status update and several help/navigation sections, and updates the page revision to v3.6.0. The Interventions heading is standardized from 'Intervention / Treatment' to 'Intervention/Treatment' and the older revision tag v3.5.5 is removed.SummaryDifference0.4%

- Check20 days agoChange DetectedThe page revision label changed from v3.5.4 to v3.5.5, indicating an updated page template/version rather than a change to the study data or main content.SummaryDifference0.0%

- Check41 days agoChange DetectedThe revision tag on the page was updated from Revision: v3.5.3 to Revision: v3.5.4, signaling a new software build. This is a routine maintenance update and does not modify the study details, eligibility criteria, or results content on the page.SummaryDifference0.0%

- Check55 days agoChange DetectedThe page now displays Revision: v3.5.3, replacing Revision: v3.5.2, indicating a newer page/document revision rather than substantive study details.SummaryDifference0.0%

- Check69 days agoChange Detected- Site revision updated to v3.5.2 (previously v3.5.0).SummaryDifference0.0%

- Check98 days agoChange DetectedRevision note added: v3.5.0; removed revision note: v3.4.3.SummaryDifference0.0%

Stay in the know with updates to Navarixin and Pembrolizumab Combination Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Navarixin and Pembrolizumab Combination Clinical Trial page.